For: | Behboudi S, Pereira SP. Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma. World J Hepatol 2010; 2(7): 256-260 [PMID: 21161007 DOI: 10.4254/wjh.v2.i7.256] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v2/i7/256.htm |
Number | Citing Articles |
1 |
Yiqiong Jia, Zhen Zeng, Yuanyuan Li, Zhiwei Li, Lei Jin, Zheng Zhang, Lifeng Wang, Fu-Sheng Wang, Xue-feng Bai. Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression. PLOS ONE 2015; 10(2): e0117458 doi: 10.1371/journal.pone.0117458
|
2 |
Gianluigi Giannelli, Erica Villa, Michael Lahn. Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma. Cancer Research 2014; 74(7): 1890 doi: 10.1158/0008-5472.CAN-14-0243
|
3 |
Su Jong Yu, Tim F. Greten. Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of Liver Cancer 2020; 20(1): 1 doi: 10.17998/jlc.20.1.1
|
4 |
Angela D. Pardee, Hiroshi Yano, Aliyah M. Weinstein, Aaron A. K. Ponce, Alexander D. Ethridge, Daniel P. Normolle, Lazar Vujanovic, Gerald J. Mizejewski, Simon C. Watkins, Lisa H. Butterfield. Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer 2015; 3(1) doi: 10.1186/s40425-015-0077-x
|
5 |
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 2021; 29(3): 188 doi: 10.1097/PAI.0000000000000865
|
6 |
Angela D. Pardee, Jian Shi, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells. The Journal of Immunology 2014; 193(11): 5723 doi: 10.4049/jimmunol.1400725
|
7 |
Helal F. Hetta, Asmaa M. Zahran, Shima G. Mansor, Mohamed O. Abdel‐Malek, Mohamed A. Mekky, Wael A. Abbas. Frequency and Implications of myeloid‐derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus‐related hepatocellular carcinoma. Journal of Medical Virology 2019; 91(7): 1319 doi: 10.1002/jmv.25428
|
8 |
Wenkang Shang, Gabriel Komla Adzika, Yujie Li, Qike Huang, Ningding Ding, Bianca Chinembiri, Mohammad Sajjad Ibn Rashid, Jeremiah Ong'achwa Machuki. Molecular mechanisms of circular RNAs, transforming growth factor‐β, and long noncoding RNAs in hepatocellular carcinoma. Cancer Medicine 2019; 8(15): 6684 doi: 10.1002/cam4.2553
|
9 |
Yongqi Ding, Yiyang Gong, Hong Zeng, Gelin Song, Zichuan Yu, Bidong Fu, Yue Liu, Da Huang, Yanying Zhong. ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility. Aging 2023; 15(13): 6179 doi: 10.18632/aging.204827
|
10 |
JUN ZHOU, PING MA, JUN LI, XIAONAN CUI, WEI SONG. Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ gene. Molecular Medicine Reports 2016; 13(4): 3197 doi: 10.3892/mmr.2016.4884
|
11 |
Tai Hato, Andrew X Zhu, Dan G Duda. Rationally Combining Anti-VEGF Therapy with Checkpoint Inhibitors in Hepatocellular Carcinoma. Immunotherapy 2016; 8(3): 299 doi: 10.2217/imt.15.126
|
12 |
RUI XU, QIBIAO WU, YUHAN GONG, YONGZHE WU, QINGJIA CHI, DA SUN. A novel prognostic target-gene signature and nomogram based on an integrated bioinformatics analysis in hepatocellular carcinoma. BIOCELL 2022; 46(5): 1261 doi: 10.32604/biocell.2022.018427
|